OpenVSafe by OpenVAERS
Search V-safe

BWT-32017-47709

4 vaccinations 11 coded responses 25 check-ins 10 free-text entries 0 call cases
Sex
Male
Age at first dose
12-15
ZIP prefix
940 / CA
Registered
2022-01-18
Relationship
Child or adolescent in my care
Guardian
2L4-31858-15771
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-07
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-18
    Registered in v-safe
  4. 2022-01-18
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-18
    Survey response — day 0, dose 3, dependent
    MedDRA: Somnolence — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Free text: sleepy
    MedDRA releases: 2024-11 · check-in free text available
  6. 2022-01-19
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Migraine — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Free text: migraine
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-01-20
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  8. 2022-01-21
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  9. 2022-01-22
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  10. 2022-01-23
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-01-24
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2022-01-25
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2022-02-01
    Survey response — day 14, dose 3, dependent
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Worsening of ADHD symptoms
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-02-08
    Survey response — day 21, dose 3, dependent
    MedDRA: Fatigue, Somnolence — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Increased fatigue and sleepiness.
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-02-15
    Survey response — day 28, dose 3, dependent
    MedDRA: Fatigue, Irritability — Feeling: Fair
    Free text: Fatigue, irritability
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-02-22
    Survey response — day 35, dose 3, dependent
    MedDRA: Fatigue, Somnolence — Feeling: Fair
    Free text: Fatigue, sleepiness
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-03-01
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  18. 2022-04-19
  19. 2022-07-19
    Survey response — 6 months, dose 3, dependent
    MedDRA: Sleep disorder, Somnolence — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Daytime sleepiness, nighttime sleep disturbance
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-09-17
    Dose 4 — Pfizer-BioNTech
  21. 2022-09-17
    Health check-in — day 0, dose 4, dependent
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  22. 2022-09-20
    Survey response — days 1–6 daily, dose 4, dependent
    MedDRA: Somnolence — Feeling: Poor · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Sleepy
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-09-21
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  24. 2022-09-23
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  25. 2022-09-26
    Health check-in — day 7, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  26. 2022-10-03
    Survey response — day 14, dose 4, dependent
    MedDRA: Cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Bad upper respiratory tract infection: cough, congestion, fever. Tests negative for COVID.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-10-10
    Survey response — day 21, dose 4, dependent
    MedDRA: Cough — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Worsening cough
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-10-17
    Health check-in — day 28, dose 4, dependent
    Feeling: Good
    Adult check-in
  29. 2022-10-24
    Health check-in — day 35, dose 4, dependent
    Feeling: Good
    Adult check-in
  30. 2023-03-18
    Survey response — 6 months, dose 4, dependent
    MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-05-17Pfizer-BioNTech No
22021-06-07Pfizer-BioNTech No
32022-01-18Pfizer-BioNTech No
42022-09-17Pfizer-BioNTech No

Free text

Release 10 — day 0, dose 3, dependent

2022-01-18

Systemic reaction (other): sleepy

Release 10 — days 1–6 daily, dose 3, dependent

2022-01-19

Systemic reaction (other): migraine

Release 11 — day 14, dose 3, dependent

2022-02-01

Symptoms: Worsening of ADHD symptoms

Release 11 — day 21, dose 3, dependent

2022-02-08

Symptoms: Increased fatigue and sleepiness.

Release 11 — day 28, dose 3, dependent

2022-02-15

Symptoms: Fatigue, irritability

Release 11 — day 35, dose 3, dependent

2022-02-22

Symptoms: Fatigue, sleepiness

Release 12 — 6 months, dose 3, dependent

2022-07-19

Symptoms: Daytime sleepiness, nighttime sleep disturbance

Release 12 — days 1–6 daily, dose 4, dependent

2022-09-20

Systemic reaction (other): Sleepy

Release 12 — day 14, dose 4, dependent

2022-10-03

Symptoms: Bad upper respiratory tract infection: cough, congestion, fever. Tests negative for COVID.

Release 12 — day 21, dose 4, dependent

2022-10-10

Symptoms: Worsening cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCondition aggravated · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDIrritability · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSleep disorder · · ✓
SDSomnolence · · ✓
SDUpper respiratory tract infection · · ✓
SROMigraine · · ✓
SROSomnolence · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release